This study involved four major activities in estimating the current size of the epigenetics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the epigenetics market. The secondary sources used for this study include World Health Organization (WHO), World Intellectual Property Organization (WIPO), International Union of Biochemistry and Molecular Biology (IUBMB), National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), Centers for Disease Control and Prevention (CDC), American Cancer Society (ACS), American Society for Biochemistry and Molecular Biology (ASBMB), Canadian Society for Molecular Biosciences (CSMB), National Institute of Environmental Health Sciences (NIEHS), Canadian Institutes of Health Research (CIHR), Genome Canada, and Central Drugs Standard Control Organisation (CDSCO); ACS Journals; Corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global epigenetics market, which was validated through primary research.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the epigenetics market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
-
The major players in the industry and market have been identified through extensive primary and secondary research.
-
The revenues generated from the epigenetics service business of players operating in the market have been determined through secondary research and primary analysis.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Global Epigenetics Market Size: Bottom-Up Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach-
Data Triangulation
After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
-
Epigenetics includes the assessment of individual behaviors and the environment that may impact gene functions. In contrast to genetic changes, epigenetic changes can be reversed and do not change the DNA sequence of an individual.The report covers the qualitative and quantitative analysis of various products & services used in epigenetics studies by end uses such as academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinics.
Key Stakeholders
-
Contract research organizations (CROs)
-
Pharmaceutical & biopharmaceutical companies
-
Academic & research institutes
-
Venture capitalists & investors
-
Market research & consulting firms
-
Government associations
-
Medical institutions & universities
-
Hospitals & clinics
Report Objectives
-
To define, describe, and forecast the epigenetics market by product & service, method, technique, application, end user, and region
-
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
-
To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall epigenetics market
-
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa
-
To profile the key players and analyze their market shares and core competencies2
-
To track and analyze competitive developments, such as product launches, agreements, partnerships, acquisitions, and research & development activities
-
To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Product Analysis
-
Product matrix, which provides a detailed comparison of the product portfolio of each company in the epigenetics Market
Growth opportunities and latent adjacency in Epigenetics Market